Results 61 to 70 of about 49,152 (197)

Pharmacokinetics of Pamidronate in Patients With Bone Metastases [PDF]

open access: yes, 2017
Background: Pamidronate is a secondgeneration bisphosphonate used in the treatment of tumor-induced hypercalcemia and in the management of bone metastases from breast cancer, myeloma, or prostate cancer.
Flesch, G.   +6 more
core  

Pediatric chronic nonbacterial osteomyelitis of the mandible: Seattle Children’s hospital 22-patient experience

open access: yesPediatric Rheumatology Online Journal, 2020
Background Studies evaluating treatment responses for chronic nonbacterial osteomyelitis (CNO) are lacking. We aimed to measure and compare response rates of medical treatments, time to response of medical treatments among patients with CNO of the ...
Austin Gaal   +3 more
doaj   +1 more source

Risk of Acute Kidney Injury Associated With Nephrotoxic Burden in Hospitalized Patients: A Scoping Review

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 4, Page 891-904, April 2026.
Limited evidence exists synthesizing the risk of acute kidney injury (AKI) associated with the concomitant administration of multiple nephrotoxic drugs, and even less examining the concept of nephrotoxic burden. The objective of this scoping review was to (1) identify definitions of nephrotoxic burden; (2) methods used to quantify (use of calculations)
Wafa Alatawi   +6 more
wiley   +1 more source

The first pamidronate containing polymer and copolymer

open access: yes, 2006
Here we report the synthesis, characterization and hydrogelation of polymers consisting of pamidronate, a useful therapeutic ...
Yang, Zhimou   +3 more
core   +1 more source

Advanced Platelet‐Rich Fibrin in Surgical Management of Medication‐Related Osteonecrosis of the Jaw: A Prospective Case Series Study

open access: yesClinical and Experimental Dental Research, Volume 12, Issue 2, April 2026.
Abstract Background Medication‐related osteonecrosis of the jaw (MRONJ) is a severe complication associated with antiresorptive or antiangiogenic therapy. Surgical debridement is the mainstay of treatment for moderate to advanced disease, while adjunctive regenerative approaches such as advanced platelet‐rich fibrin (A‐PRF) may enhance soft tissue ...
Besim Hajdari   +5 more
wiley   +1 more source

Anatomical sector analysis of load-bearing tibial bone structure during 90 days bed rest and 1- year recovery [PDF]

open access: yes, 2011
The aim of this study was to investigate whether the bone response to long bed rest–related immobility and during subsequent recovery differed at anatomically different sectors of tibial epiphysis and diaphysis.
Sievänen, Harrir   +4 more
core  

Zebra lines of pamidronate therapy in children

open access: yes, 2007
Background: Pamidronate therapy is increasingly used in children for the treatment of low bone mineral density and increased bone fragility resulting from a spectrum of conditions.
Cundy, P., Al Muderis, M., Azzopardi, T.
core   +1 more source

Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report

open access: yesBMC Veterinary Research
Background Pamidronate is used for the treatment of hypercalcemia. However, a rare but potential adverse event of pamidronate treatment is hypocalcemia.
Ye-In Oh   +6 more
doaj   +1 more source

Intravenous pamidronate for refractory lymphedema

open access: yes, 2011
Background: Based on beneficial reports of pamidronate use for reflex sympathetic dystrophy in reduction of pain and swelling, this drug can be studied as a novel treatment for refractory lymphedema.
Masoudpour, H.   +4 more
core  

Radiographic long bone appearance in a child administered cyclical pamidronate

open access: yes, 2003
The appearance of this radiograph caused considerable concern in the casualty department. It shows the left wrist of an 11 year old girl and was taken following suspicion of a fracture.
Gregory, J.W.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy